Journey Medical Corp Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Journey Medical Corp stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $158.00K, a 4.24% decline year-over-year.
- Journey Medical Corp stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $72.00K, a 4.00% decline year-over-year.
- Journey Medical Corp stock issued during period, value, stock options exercised for the quarter ending 2025-06-30 was $165.00K, a 432.26% increase year-over-year.
- Journey Medical Corp stock issued during period, value, stock options exercised for the quarter ending 2025-03-31 was $75.00K, a 10.29% increase year-over-year.
- Journey Medical Corp stock issued during period, value, stock options exercised for fiscal 2024 was $207.00K, a 71.07% increase from fiscal 2023.
- Journey Medical Corp stock issued during period, value, stock options exercised for fiscal 2023 was $121.00K, a 14.79% decline from fiscal 2022.
- Journey Medical Corp stock issued during period, value, stock options exercised for fiscal 2022 was $142.00K, a 1928.57% increase from fiscal 2021.
- Journey Medical Corp stock issued during period, value, stock options exercised for fiscal 2021 was $7.00K, a 46.15% decline from fiscal 2020.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $158.00K 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $72.00K 10-Q · filed 2026-05-13 | |
| 2025-06-30 | $165.00K 10-Q · filed 2026-08-12 | $348.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $75.00K 10-Q · filed 2026-05-13 | $214.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $45.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $207.00K 10-K · filed 2026-03-26 |
| 2024-09-30 | $63.00K 10-Q · filed 2025-11-12 | $258.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $31.00K 10-Q · filed 2025-08-12 | $217.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $68.00K 10-Q · filed 2025-05-15 | $189.00K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $96.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $121.00K 10-K · filed 2025-03-27 |
| 2023-09-30 | $22.00K 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $3.00K 10-Q · filed 2024-08-13 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $142.00K 10-K · filed 2024-03-29 |
| 2022-09-30 | $31.00K 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $111.00K 10-Q · filed 2023-08-10 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $7.00K 10-K · filed 2023-03-31 |
| 2021-03-31 | $7.00K 10-Q · filed 2022-05-10 | |
| 2020-12-31 | $13.00K 10-K · filed 2022-03-28 |